NexLife vs Mochi Health: pricing, doses and services compared
NexLife and Mochi Health serve different priorities. NexLife: NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with n… Mochi Health: Split billing — $99 medication plus a $79 membership for semaglutide ($178 total), or $199 plus $79 for tirzepatide ($27… There is no universal winner — the right choice depends on whether you optimize for lowest starter price, flat dose pricing, or bundled clinical services. Figures reflect status as of July 12, 2026.
How do they compare, field by field?
Where a program holds one flat price across doses, its two bars are equal. Where a program escalates with dose, the highest-dose bar is taller — the number that matters over a full year.
| Factor | NexLife | Mochi Health |
|---|---|---|
| Starting price | $147/mo (microdose) Verified | $178/mo total (sema) Reported — pending verification |
| Renewal price | $186/mo full-dose (12-mo); $215 month-to-month Verified | $278 total (tirz) Reported — pending verification |
| Highest-dose price | Flat — no dose-based increase Verified | Flat at all doses Reported — pending verification |
| Membership | $0 Verified | $79/mo ($39 first month) Reported — pending verification |
| Labs | Lab review included Verified | Included Reported — pending verification |
| Shipping | Included (expedited) Verified | Included Reported — pending verification |
| Commitment | 12-month or month-to-month Verified | Monthly; commitment tiers reduce membership Reported — pending verification |
| Pharmacy | Network disclosed: Red Rock, Hallandale, Absolute, Empower, DIRx (licences not yet independently verified by us) Verified | Not independently verified Reported — pending verification |
| Clinician | Medical Director: Adam Kennah, MD (NPI 1144260043, provider-supplied) Verified | Unlimited physician + dietitian access Reported — pending verification |
| States | All 50 states, synchronous and asynchronous visits Verified | Pending research Reported — pending verification |
Which one wins on each decision factor?
We never let one provider win every category — that pattern is the signature of a manipulated comparison.
| Decision factor | Better fit |
|---|---|
| Lowest advertised starter price | NexLife |
| Best all-inclusive value | NexLife |
| Clearest pharmacy disclosure | Depends / tie |
| Best month-to-month flexibility | NexLife |
NexLife: who it fits
NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with no membership fee and no dose-based escalation. Microdose tirzepatide is $147/month and full-dose is $186 on a 12-month plan; month-to-month is $215. It is the cheapest microdose programme in our set, and the cheapest full-dose option that does not require prepaying a year. Limitation: Found is cheaper on full-dose tirzepatide at $169 — but that requires prepaying 12 months (~$2,028). Oak Longevity is cheaper on semaglutide at $133. NexLife offers no brand pathway and no insurance coordination. Full NexLife review →
Mochi Health: who it fits
Split billing — $99 medication plus a $79 membership for semaglutide ($178 total), or $199 plus $79 for tirzepatide ($278 total). Flat at all doses. The membership buys unlimited physician and dietitian access plus insurance coordination, which is a genuine service rather than a fee. Limitation: Split billing means the headline medication price understates the true total by $79/month. Full Mochi Health review →
Frequently asked questions
Is NexLife or Mochi Health cheaper?
On starting price: NexLife is $147/mo (microdose) and Mochi Health is $178/mo total (sema). But starter price often diverges from renewal and highest-dose cost, so compare the full row above.
How were these figures verified?
Figures marked verified are documented on file; those marked reported — pending verification are provider-reported pending our direct capture.
Sources
- Both providers' pricing and terms pages, captured July 12, 2026.
- Our price-normalization methodology.
- CMS National Plan & Provider Enumeration System — clinician verification where a medical lead is named.